文献速递免疫规划卫生政策与健康促进

乙肝疫苗接种与中枢脱髓鞘:法国药物警戒20年624例报告的分析

Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
PubMed 文献 · Vaccine · 2019-03-06

该研究分析法国药物警戒系统1980-2000年报告的624例中枢脱髓鞘病例(其中422例为多发性硬化发病病例),并开展观察值与预期值比较。报告率在1995-1997年达峰,总体报告率为每百万剂售出疫苗6.5例,观察病例数始终低于预期数。结果不支持乙肝疫苗与多发性硬化之间存在强关联。

要点

  • 624例中枢脱髓鞘报告中女性占73.2%,平均年龄29.8岁。
  • 1995-1997年报告占59.8%,主要发生在加强针后(46.3%)。
  • 观察值与预期值分析结果不确定,观察病例数低于预期。

核心结论

  • 结果不支持乙肝疫苗与多发性硬化之间存在强关联,但关联性质仍不明确。

研究设计与样本

  • 分析1980-2000年法国药物警戒系统所有验证报告,共624例中枢脱髓鞘病例,其中422例为多发性硬化发病病例。
  • 计算每百万剂售出疫苗的报告率,并采用个体法和人年法进行观察值与预期值比较,按性别分层。

主要发现

  • 女性占73.2%(n=457),平均年龄29.8岁(SD=11.1)。
  • 事件报告在1995-1996年和1997年达峰,合计占59.8%(n=373)。
  • 事件主要发生在加强针后(46.3%,n=289)。
  • 总体报告率为每百万剂售出疫苗6.5例。
  • 观察值与预期值分析结果不确定,观察病例数始终低于预期数。

临床怎么用

  • 当前针对新生儿的推荐以及可能对高风险成人的补种策略,在低流行国家仍应是首选策略。

局限性

  • 报告数据存在漏报可能,且观察值与预期值分析结果不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Confidence in vaccines is essential for achieving targeted immunization coverage. The current skepticism about vaccine safety feeds on controversies such as the suspicion about a link between hepatitis B (HB) vaccination and central demyelination (CD) after the massive HB immunization campaign in France in 1994-2000. This study assesses the robustness of this signal by analysing all validated cases reported in 1980-2000 and by conducting observed-to-expected (OE) comparisons. METHODS: After characterizing case profiles, reporting rates per 1,000,000 vaccine doses sold were computed for the period and per year. OE comparisons were conducted by using individual-based and person-year approaches and were stratified by gender. FINDING: A total of 624CD cases including 422 incident cases of multiple sclerosis (MS) were reported over 20 years. Women accounted for 73.2% (n = 457). Mean age was 29.8 years (SD = 11.1). Incidence of events peaked in 1995-1996 and 1997, these years accounting for 59.8% (n = 373) of cases. Events were mainly reported after booster doses (46.3%, n = 289). The overall reporting rate was 6.5 per 1,000,000 doses sold. The OE analyses produced inconclusive results, the number of observed cases remaining below the expected number. CONCLUSIONS: The complete disjunction between target and joint populations in the 1990s French HB immunization campaign created an unpreceded situation with ∼26 million of adults exposed at the age of MS onset. Two findings are noteworthy: the non-random distribution of reports according to the rank of vaccination or years of survey, and the fact that the number of reports sometimes approached the baseline incidence of MS, irrespective of underreporting. While the nature of the link remains unclear, our results are not consistent with a strong association between HB vaccine and MS. Current recommendations targeting newborns with a possible catch-up of at-risk adults should remain the preferred strategy in low-endemic countries.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mouchet J, Bégaud B. Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period. Vaccine. 2019. PMID: 30851966. doi:10.1016/j.vaccine.2019.02.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。